Fecundis Lab is a reproductive biotechnology company focused on assisted reproduction. We are the team behind HyperSperm, the first sperm capacitation kit developed to address a critical and long-overlooked biological step in IVF workflows. Our work combines reproductive biology, translational science, and product development to turn cutting-edge science into practical innovation for fertility care. By focusing on sperm capacitation, we are advancing an area with major clinical relevance but limited product innovation to date. We are committed to developing science-driven solutions that improve the consistency, efficiency, and overall performance of ART.
| Website | http://www.fecundis.com |
| Employees | 11 (10 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Assisted Reproductive Technology, In Vitro Fertilization, Ivf Technology, Reproductive Medicine, Reproductive Endocrinology, Infertility Solutions, Fertility Testing, Affordable Fertility, Fertility Clinic, Fertility Preservation, Family Planning, Egg Freezing, Genetic Testing, Sperm Donation, Surrogacy Services |
| Competitors | Labcorp, Quest Diagnostics, Georgia Reproductive Specialists, Sartorius, Myriad Genetics, California Cryobank LLC, The Egg Donor Program, IVF1, OvaScience, CooperSurgical +18 more (view full list) |
Looking for a particular Fecundis Lab employee's phone or email?
Arina Rogozina is the CEO of Fecundis Lab.
10 people are employed at Fecundis Lab.
Fecundis Lab is based in Barcelona, Catalonia.